Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn

UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds

The Guardian

Die Pharma-Firma GlaxoSmithKline (GSK) überzieht diese Tage die Republik wieder mit angsterzeugender Werbung in den Medien, z.B. mit ganzseitigen Zeitungsanzeigen die reisserisch titeln: „RSV-Saison erreicht kritische Phase“.

Werbung von Pharmafirmen in der Laienpresse ist eigentlich aus gutem Grund verboten. Ein Blick nach Amerika mit seinen hundertausenden Toten durch Werbung für Opioide sollte genügen.

Dennoch umgehen Pharmafirmen zunehmend aggressiv das Werbeverbot – wir von #MEZIS haben deswegen 2025 eine Petition in den Bundestag eingebracht.

Aktuell macht GSK prominent Werbung mit einem Arzt, Dr. Frühwein. Der Mediziner behauptet vollmundig: „Die Impfung ist eine wichtige Maßnahme um Lebensqualität zu erhalten“. Was viele nicht wissen, Dr. Frühwein betreibt auch das „Forum Impfen e.V“. Sich selbst bezeichnet der Verein als „die größte umfangreichste deutsche ...

... hier weiterlesen:
https://mezis.de/das-forum-impfen-e-v-und-die-angsterzeugende-laien-werbung-fuer-die-rsv-impfung-von-glaxosmithkline/

#mezis #pharma #gsk

ギャルしか勝たーん
自己肯定感爆アゲ↑
https://www.youtube.com/watch?v=JQyNTKyMODw

#ウマ娘 #藤田ことね #GSK

GSK☆

YouTube
GSK to buy food allergy drug maker RAPT in $2.2bn deal

US-based biotech firm is developing treatment for allergies such as nuts, milk and eggs in children and adults

The Guardian
GSK to buy food allergy drug maker RAPT in $2.2bn deal

US-based biotech firm is developing treatment for allergies such as nuts, milk and eggs in children and adults

The Guardian
GSK to buy food allergy drug maker RAPT in $2.2bn deal

US-based biotech firm is developing treatment for allergies such as nuts, milk and eggs in children and adults

The Guardian
ABL Bio CEO Lee Sang-hoon announced at the JP Morgan Healthcare Conference that the company expects to secure new global partnerships beyond GSK, Eli Lilly, and Sanofi, following multi-trillion won licensing deals and ongoing clinical progress.
#YonhapInfomax #ABLBio #GSK #EliLilly #LicensingDeal #ClinicalProgress #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=100204
ABL Bio Expects New Partnerships Beyond GSK and Lilly

ABL Bio CEO Lee Sang-hoon announced at the JP Morgan Healthcare Conference that the company expects to secure new global partnerships beyond GSK, Eli Lilly, and Sanofi, following multi-trillion won licensing deals and ongoing clinical progress.

Yonhap Infomax
Samsung Biologics has signed a $280 million deal to acquire GSK's biopharmaceutical manufacturing facility in Maryland, marking its first US production base and expanding its global CMO capacity.
#YonhapInfomax #SamsungBiologics #GSK #BiopharmaceuticalManufacturing #Acquisition #4147BillionWon #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=96556
Samsung Biologics Signs $280 Million Deal to Acquire GSK Biopharmaceutical Manufacturing Facility in US

Samsung Biologics has signed a $280 million deal to acquire GSK's biopharmaceutical manufacturing facility in Maryland, marking its first US production base and expanding its global CMO capacity.

Yonhap Infomax
Avant de partir en week-end, regardons une dernière petite vidéo: Éric Muraille #ULB - Université libre de #Bruxelles et Xavier De Bolle Université de #Namur. Prix #GSK francophone pour leurs travaux sur le développement rationnel de #vaccins vivants atténués plus sûrs contre la #brucellose grâce au Transposon Sequencing @ULBRecherche
https://youtu.be/xyYuDtAG4eM

Hệ thống Tiêm chủng VNVC chính thức ra mắt vắc xin thế hệ mới phòng viêm phổi do virus hợp bào hô hấp (RSV) cho người lớn, từ 60 tuổi trở lên và người có bệnh lý nền mạn tính. Vắc xin do tập đoàn GSK (Anh) phát triển, ứng dụng công nghệ tiên tiến, giúp phòng ngừa hiệu quả các bệnh hô hấp nặng do RSV – nguyên nhân gây viêm phổi và nhập viện hàng đầu ở người cao tuổi. Việc tiêm chủng được khuyến cáo nhằm tăng cường miễn dịch và bảo vệ sức khỏe mùa dịch.

#VaccineRSV #VNVC #GSK #ViêmPhổi #SứcKhỏe